Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 24.4.2017 | EN | Official Journal of the European Union | C 129/37 |

---

Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)

(Case T-157/17)

(2017/C 129/57)

Language in which the application was lodged: English

Parties

Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)

Details of the proceedings before EUIPO

Applicant: Applicant

Trade mark at issue: EU word mark ‘ILLUMINA’ — Application for registration No 11 934 239

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 in Case R 1187/2016-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO and the other party, should it intervene, to pay the costs of proceedings, including those incurred before the Board of Appeal. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009; |

|  |  |
| --- | --- |
| — | Infringement of Articles 75, 42(2) and 64(1) of Regulation No 207/2009. |

---

[Top](#document1)